A Non-Profit Biotech Model; Therapies for Rare Diseases - Dr. Ashley Winslow

Talking Biotech with Dr. Kevin Folta
09/09/2023 47 min Episodio 414
A Non-Profit Biotech Model; Therapies for Rare Diseases - Dr. Ashley Winslow

Listen "A Non-Profit Biotech Model; Therapies for Rare Diseases - Dr. Ashley Winslow"

Descargar episodio Ver en sitio original

Episode Synopsis


This episode has two parts. The first part discusses how Odylia Therapeutics is addressing rare disease, using a novel non-profit model. The second half address two rare genetic eye diseases and the approaches being designed to address them. Dr. Ashley Winslow, CEO/CSO of Odylia, describes how a non-profit is well suited to address these rare diseases, using strategies that leverage capacities in rare disease patient communities coupled to their expertise in drug discovery.  

More episodes of the podcast Talking Biotech with Dr. Kevin Folta

A Biotech Probiotic to Enhance Fiber - Dr. Zack Abbott 02/11/2025
Peer Review and Rigor in Controversial Science - Cam English, Dr. Liza Lockwood 19/10/2025
Everyone Else is Lying to You - Pandemic Disinformation - Dr. Jonathan Howard 11/10/2025
Targeting RNA with Therapeutics - Dr. Matthew Disney 05/10/2025
Biotech Takes On the Screw Worm - Dr. Max Scott 27/09/2025
Attacking Cancers through Neoantigens - Dr. Jackie Douglass 20/09/2025
Drug Discovery in the Synapse - Derek Small 13/09/2025
Correcting the Veratasium Glyphosate - Monsanto Episode 06/09/2025
Unintended Effects of HPV and Shingles Vaccines - Dr. Kevin Folta 23/08/2025
Revolutionizing Agriculture with RNA Technology - Dr. Andrey Zarur 16/08/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA